DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

Array BioPharma (NASDAQ: ARRY)

7.63 -0.18 (-2.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARRY $7.63 -2.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.48
Previous Close $7.81
Daily Range $7.41 - $8.01
52-Week Range $2.98 - $8.01
Market Cap $1.0B
P/E Ratio -10.14
Dividend (Yield) $0.00 (0.0%)
Volume 9,510,009
Average Daily Volume 3,321,519
Current FY EPS -$0.70





Array BioPharma (ARRY) Description

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Website:

News & Commentary Rss Feed

Does This 50% Price Target Hike For Array BioPharma Inc. Make Sense?

Stifel Nicolaus boosted its price target on cancer drug developer Array BioPharma by a substantial amount on Monday. Is this price hike warranted or is it full of fluff?

Array BioPharma (ARRY) Jumps: Stock Adds 9.8% in Session - Tale of the Tape

Trio Of Wall Street Firms Up Array BioPharma Price Targets

Today's Perilous Reversal Stock: Array BioPharma (ARRY)

Benzinga's Weekend M&A Chatter

Why Array Biopharma Inc's Shares Skyrocketed

Is this meaningful? Or just another movement?

Why Shares Of Array Biopharma Are Surging More Than 35%

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Morning Market Gainers

Why You Shouldn't Bet Against Array BioPharma (ARRY) Stock - Tale of the Tape

See More ARRY News...

ARRY's Top Competitors

ARRY $7.63 (-2.24%)
Current stock: ARRY
AMGN $158.42 (-0.82%)
Current stock: AMGN
GILD $105.03 (-1.94%)
Current stock: GILD
BIIB $358.23 (-1.16%)
Current stock: BIIB